Skip to main content

Tim Willson

September 24, 2018

Assay Development, Chemical Libraries, Cheminformatics, Computational Drug Design, Machine Learning, Allosteric Modulators, Chemical Biology, Chemical Probes, Drug Discovery, Fragment Based Drug Design, Protein Kinase Inhibitors, Protein Kinases, Rare Diseases, Structure Activity Relationship, Synthetic Chemistry

Xiaodong Wang

September 24, 2018

Animal Models, Assay Development, Computational Drug Design, HPLC, LC-MS/MS, NMR Spectroscopy, X-ray Crystallography, Blood-brain Barrier, Cancer, Chemical Probes, Drug Discovery, Immunotherapy, Obesity, Pharmacokinetics, Protein Kinase Inhibitors, Structure Activity Relationship, Tumor Microenvironment

Stephen Frye

September 24, 2018

ADME profiling, Chemical Libraries, Computational Drug Design, NMR Spectroscopy, Organic Synthesis Biophysics, Cancer, Chemical Biology, Chemical Probes, Chromatin, Drug Discovery, Epigenetics, Protein Kinase Inhibitors, Structural Biology, Structure Activity Relationship

Alex Tropsha

September 24, 2018

ADME profiling, Artificial Intelligence, Cheminformatics, Computational Drug Design, In Silico Modeling, Machine Learning, Bioinformatics, Cheminformatics, Computational Modeling, Data Science, Drug Delivery, Drug Discovery, Drug Safety, Educational Research, Fragment Based Drug Design, G Protein-coupled Receptors, Machine Learning, Toxicology